Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Specimen Handling 38Magnetic Resonance Spectroscopy 33Biopsy 16Radiation 15Cyclophosphamide 15Radiotherapy 14Vincristine 12Leucovorin 11Dexamethasone 11Carboplatin 11Etoposide 10Cisplatin 10Cytarabine 9Calcium Dobesilate 9dexamethasone acetate 8dexamethasone 21-phosphate 8auricularum 8Fluorouracil 8X-Rays 7Standard of Care 7Radiotherapy, Intensity-Modulated 7Practice Guidelines as Topic 7Platinum 7Doxorubicin 71,2-diaminocyclohexaneplatinum II citrate 7merphos 6dehydroftorafur 6Taxes 6Methotrexate 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × relugolix × 30 days × Clear all
NCT04423211 2026-05-15

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Eastern Cooperative Oncology Group

Phase 3 Recruiting
804 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡